Medicalgorithmics S.A. (MDG.WA)
PLN 25.25
(2.02%)
PLN 25.25
(2.02%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 29.06 Million PLN | 1.42% |
| 2022 | 28.65 Million PLN | -57.24% |
| 2021 | 67.01 Million PLN | -11.87% |
| 2020 | 76.03 Million PLN | 29.89% |
| 2019 | 58.54 Million PLN | -31.39% |
| 2018 | 85.32 Million PLN | -0.27% |
| 2017 | 85.54 Million PLN | -44.79% |
| 2016 | 154.94 Million PLN | 4933.62% |
| 2015 | 3.07 Million PLN | -24.93% |
| 2014 | 4.1 Million PLN | 58.89% |
| 2013 | 2.58 Million PLN | 46.67% |
| 2012 | 1.75 Million PLN | 12.24% |
| 2011 | 1.56 Million PLN | 85.36% |
| 2010 | 845.7 Thousand PLN | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 27.54 Million PLN | -1.45% |
| 2024 Q1 | 27.95 Million PLN | -3.83% |
| 2023 Q4 | 29.06 Million PLN | 5.1% |
| 2023 Q1 | 36.15 Million PLN | 26.15% |
| 2023 Q2 | 24.96 Million PLN | -30.95% |
| 2023 Q3 | 27.65 Million PLN | 10.79% |
| 2023 FY | 29.06 Million PLN | 1.42% |
| 2022 Q2 | 65.87 Million PLN | -0.54% |
| 2022 Q1 | 66.23 Million PLN | -1.17% |
| 2022 FY | 28.65 Million PLN | -57.24% |
| 2022 Q4 | 28.65 Million PLN | 40.22% |
| 2022 Q3 | 20.43 Million PLN | -68.98% |
| 2021 Q3 | 82.46 Million PLN | 0.91% |
| 2021 Q4 | 67.01 Million PLN | -18.73% |
| 2021 Q2 | 81.72 Million PLN | -16.6% |
| 2021 FY | 67.01 Million PLN | -11.87% |
| 2021 Q1 | 97.98 Million PLN | 28.86% |
| 2020 Q1 | 64.74 Million PLN | 10.6% |
| 2020 Q2 | 85.44 Million PLN | 31.97% |
| 2020 Q3 | 83.63 Million PLN | -2.12% |
| 2020 Q4 | 76.03 Million PLN | -9.08% |
| 2020 FY | 76.03 Million PLN | 29.89% |
| 2019 FY | 58.54 Million PLN | -31.39% |
| 2019 Q4 | 58.54 Million PLN | -9.21% |
| 2019 Q1 | 111.54 Million PLN | 30.73% |
| 2019 Q3 | 64.48 Million PLN | -2.26% |
| 2019 Q2 | 65.97 Million PLN | -40.86% |
| 2018 Q1 | 77.57 Million PLN | -9.32% |
| 2018 FY | 85.32 Million PLN | -0.27% |
| 2018 Q4 | 85.32 Million PLN | 3.15% |
| 2018 Q3 | 82.71 Million PLN | -5.85% |
| 2018 Q2 | 87.85 Million PLN | 13.25% |
| 2017 FY | 85.54 Million PLN | -44.79% |
| 2017 Q3 | 93.28 Million PLN | -3.89% |
| 2017 Q2 | 97.05 Million PLN | -9.4% |
| 2017 Q1 | 107.12 Million PLN | -30.86% |
| 2017 Q4 | 85.54 Million PLN | -8.29% |
| 2016 FY | 154.94 Million PLN | 4933.62% |
| 2016 Q4 | 154.94 Million PLN | 65.43% |
| 2016 Q3 | 93.66 Million PLN | -5.26% |
| 2016 Q1 | 91.83 Million PLN | 2883.28% |
| 2016 Q2 | 98.86 Million PLN | 7.66% |
| 2015 Q1 | 4.73 Million PLN | 15.46% |
| 2015 Q3 | 6.44 Million PLN | -42.48% |
| 2015 Q4 | 3.07 Million PLN | -52.22% |
| 2015 FY | 3.07 Million PLN | -24.93% |
| 2015 Q2 | 11.2 Million PLN | 136.58% |
| 2014 Q1 | 5.38 Million PLN | 108.84% |
| 2014 Q3 | 4.6 Million PLN | -53.5% |
| 2014 Q4 | 4.1 Million PLN | -11.02% |
| 2014 FY | 4.1 Million PLN | 58.89% |
| 2014 Q2 | 9.9 Million PLN | 83.88% |
| 2013 FY | 2.58 Million PLN | 46.67% |
| 2013 Q1 | 2.39 Million PLN | 36.21% |
| 2013 Q3 | 2.6 Million PLN | -56.65% |
| 2013 Q4 | 2.58 Million PLN | -1.08% |
| 2013 Q2 | 6.01 Million PLN | 151.1% |
| 2012 FY | 1.75 Million PLN | 12.24% |
| 2012 Q4 | 1.75 Million PLN | 0.0% |
| 2011 FY | 1.56 Million PLN | 85.36% |
| 2010 FY | 845.7 Thousand PLN | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Adiuvo Investments S.A. | 45.77 Million PLN | 36.509% |
| Genomtec S.A. | 4.45 Million PLN | -553.146% |
| Medinice S.A. | 1.51 Million PLN | -1819.749% |
| Synektik Spólka Akcyjna | 146.03 Million PLN | 80.097% |